CA2692909A1 - Gene marqueur et procede pour la detection d'un promoteur de tumeur - Google Patents

Gene marqueur et procede pour la detection d'un promoteur de tumeur Download PDF

Info

Publication number
CA2692909A1
CA2692909A1 CA 2692909 CA2692909A CA2692909A1 CA 2692909 A1 CA2692909 A1 CA 2692909A1 CA 2692909 CA2692909 CA 2692909 CA 2692909 A CA2692909 A CA 2692909A CA 2692909 A1 CA2692909 A1 CA 2692909A1
Authority
CA
Canada
Prior art keywords
gene
marker
genes
tumor
test substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2692909
Other languages
English (en)
Inventor
Katsutoshi Ohno
Hideki Maeshima
Toshihiro Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissin Foods Holdings Co Ltd
Original Assignee
Nissin Foods Holdings Co., Ltd.
Katsutoshi Ohno
Hideki Maeshima
Toshihiro Yamada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Foods Holdings Co., Ltd., Katsutoshi Ohno, Hideki Maeshima, Toshihiro Yamada filed Critical Nissin Foods Holdings Co., Ltd.
Publication of CA2692909A1 publication Critical patent/CA2692909A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2692909 2007-06-28 2008-06-27 Gene marqueur et procede pour la detection d'un promoteur de tumeur Abandoned CA2692909A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2007-170872 2007-06-28
JP2007170872 2007-06-28
JP2007-208833 2007-08-10
JP2007208833 2007-08-10
PCT/JP2008/061766 WO2009001939A1 (fr) 2007-06-28 2008-06-27 Gène marqueur et procédé pour la détection d'un promoteur de tumeur

Publications (1)

Publication Number Publication Date
CA2692909A1 true CA2692909A1 (fr) 2008-12-31

Family

ID=40185748

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2692909 Abandoned CA2692909A1 (fr) 2007-06-28 2008-06-27 Gene marqueur et procede pour la detection d'un promoteur de tumeur

Country Status (5)

Country Link
US (2) US20100330561A1 (fr)
EP (1) EP2177609B1 (fr)
JP (1) JP5328647B2 (fr)
CA (1) CA2692909A1 (fr)
WO (1) WO2009001939A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096154A2 (fr) * 2009-02-20 2010-08-26 Onconome, Inc. Compositions et méthodes de diagnostic et de pronostic de cancer colorectal
JP5866598B2 (ja) * 2011-02-22 2016-02-17 公益財団法人神奈川科学技術アカデミー 発がんプロモーション活性の検出方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593084B2 (en) * 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US20050255458A1 (en) * 2002-08-14 2005-11-17 Hanan Polansky Drug discovery assays based on the biology of chronic disease
JP4194080B2 (ja) 2003-02-19 2008-12-10 茂 森村 膵癌検出用マーカー
WO2005024020A1 (fr) * 2003-09-05 2005-03-17 Olympus Corporation Procede de depistage de la carcinogenicite de produits chimiques
JP5629894B2 (ja) 2004-12-07 2014-11-26 国立大学法人大阪大学 甲状腺乳頭癌を診断するための新規のマーカー
JP4806234B2 (ja) 2005-08-26 2011-11-02 一般財団法人 化学物質評価研究機構 被検物質の発がん性予測方法

Also Published As

Publication number Publication date
WO2009001939A1 (fr) 2008-12-31
EP2177609A4 (fr) 2011-03-30
US20100330561A1 (en) 2010-12-30
US20140065632A1 (en) 2014-03-06
EP2177609B1 (fr) 2014-12-10
JP5328647B2 (ja) 2013-10-30
EP2177609A1 (fr) 2010-04-21
JPWO2009001939A1 (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
Josse et al. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds
Datson et al. Expression profiling in laser‐microdissected hippocampal subregions in rat brain reveals large subregion‐specific differences in expression
KR101183620B1 (ko) 지방조직 유래의 간엽줄기세포를 포함하는 파킨슨병 진단용 조성물 및 파킨슨병 진단용 바이오마커
JP2011526693A (ja) 転移に関連する徴候および決定因子、ならびにそれらの使用方法
Mohr et al. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells
EP2875360B1 (fr) Dosage in vitro permettant de prédire la cytotoxicité tubulaire proximale rénale
Kausch et al. Biomarkers for exposure to estrogenic compounds: gene expression analysis in zebrafish (Danio rerio)
Shih et al. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes
Unami et al. Comparison of gene expression profiles between white and brown adipose tissues of rat by microarray analysis
Robeck et al. Multi-tissue methylation clocks for age and sex estimation in the common bottlenose dolphin
US20140065632A1 (en) Marker gene for detection of tumor promoter, and method for detection of tumor promoter
CA2803677C (fr) Analyses de l'expression de genes pour caracteriser et identifier des composes genotoxiques
Chen et al. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer
Oğuztüzün et al. Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells
Weiland et al. Characterization of primary rat proximal tubular cells by gene expression analysis
JP4032047B2 (ja) 結腸直腸癌のＴＰとＤＰＤｍＲＮＡ発現レベルの比率と５−ＦＵ治療患者における無病生存率の相関
CN107779503A (zh) 阿尔茨海默相关的差异表达基因及其应用
Borlon et al. Identification of p53-dependent genes potentially involved in UVB-mediated premature senescence of human skin fibroblasts using siRNA technology
US20220267856A1 (en) Internal Standard Gene
KR101194260B1 (ko) 디에틸스틸베스트롤에 의해 유도된 생식계 유전독성을 이용한 유전독성물질 검출용 키트 및 이의 검출 방법
CN114015781B (zh) 一种LncRIM基因的检测试剂盒及其应用
KR102610577B1 (ko) 페놀 노출 여부 평가용 바이오마커 및 이를 이용한 페놀 노출 여부 평가 방법
KR102074523B1 (ko) 간독성 유발 물질 예측용 바이오마커 조성물 및 이를 이용한 간독성 유발 물질의 스크리닝 방법
DuPré et al. AIM 3. Involvement of fine particulate matter exposure with gene expression pathways in breast tumor and adjacent-normal breast tissue
CN101993930A (zh) 一种bcl-2基因的原位杂交检测试剂盒及其检测方法和应用

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140627